UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003737
Receipt No. R000004512
Scientific Title Phase 2 study of Pemetrexed + Carboplatin + Bevacizumab as first line therapy for nonsquamous non-small cell lung cancer with EGFR Mutation (CJLSG0910)
Date of disclosure of the study information 2010/06/11
Last modified on 2019/03/31 05:48:48

No. Disposal Last modified on Item of update
1 Insert 2010/06/11 14:07:54
2 Update 2011/06/13 12:24:29 Name of person sending information
Organization
Division name
Address
3 Update 2011/12/16 11:10:48 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2013/12/16 21:01:17 TEL
Email
Address
Address
TEL
5 Update 2014/05/01 15:56:15 Recruitment status
6 Update 2016/06/13 17:41:46 Name of primary sponsor
Organization
Organization
Organization
Category of Funding Organization
7 Update 2018/06/29 18:51:40 Email1
8 Update 2019/03/31 05:48:48 Recruitment status
Date of IRB
Last follow-up date


Contact us.